A New Jersey drug company says Bremolanotide, which stimulates the brain, rather than the genitals, may be the long-sought female version of Viagra. The drug is still in preclinical tests.
PT-141, a nasal spray that is perhaps the world’s first legitimate aphrodisiac, may hit the market in under three years. The Observer wonders whether such a “sure thing” will trivialize the emotional aspect of relationships.